Search

everythinglearnresearchcommunity

for

Search:↓

The COVID-19 quarantine in Turkey disrupted dermatological care, increased stress-related skin issues, and showed the need for psychological support and teledermatology.

A woman experienced sudden hair graying and loss after a COVID-19 vaccine, which improved with treatment.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

The COVID-19 pandemic led to fewer dermatology patients, more stress-related skin conditions during the crisis, and a rise in contact dermatitis after, with ongoing concerns for public health and treatment delays.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Some COVID-19 patients in Saudi Arabia had skin symptoms, with rashes being the most common.

Topical Minoxidil is effective for hair loss after COVID-19.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

No significant link between male pattern baldness and severe Covid-19, but some shared biological pathways exist.

Most hospitalized COVID-19 survivors in the study experienced long-term symptoms, affecting their daily life and mental functions.

Long COVID causes lasting symptoms and needs ongoing care.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Minoxidil can improve hair growth in some patients with woolly hair due to LIPH variants, with varying responses and mild side effects.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

Quarantine stress likely worsened hair loss in women, but video consultations helped manage their condition and reduce anxiety.

A patient developed a severe skin reaction and died after taking hydroxychloroquine for COVID-19.

Patients reduced searches for dermatology issues during COVID-19, indicating a need for better telehealth services.

Testosterone's effects on COVID-19 are unclear and need more research.

The French COVID-19 lockdown caused delays in diagnosing new melanoma cases, making them more severe.